Search Results for:

Professionals across the drug development pipeline know well the daily struggle of staying current with a multiplying volume of multitudinous types of information: peer-reviewed scientific research, patent filings, clinical trials data, news and competitive briefs, conference abstracts and posters, and more.

This one-day conference held in the Washington offices of the Copyright Office was the second in a series of conferences under the aegis of WIPO and the USCO to help establish an appropriate legal framework to consider the implications of AI (in its various applications and forms).